| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,707 |
787 |
$59K |
| 59426 |
|
863 |
442 |
$26K |
| 99233 |
Prolong inpt eval add15 m |
682 |
220 |
$15K |
| 81002 |
|
3,027 |
1,839 |
$6K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
391 |
334 |
$5K |
| 59425 |
|
342 |
267 |
$5K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
274 |
225 |
$3K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
65 |
55 |
$2K |
| 86780 |
|
322 |
306 |
$2K |
| 59514 |
|
100 |
76 |
$2K |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
42 |
31 |
$2K |
| 85027 |
|
374 |
344 |
$899.39 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
29 |
28 |
$537.46 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
174 |
162 |
$385.99 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
14 |
13 |
$385.99 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14 |
13 |
$352.99 |
| 99223 |
Prolong inpt eval add15 m |
88 |
76 |
$293.96 |
| 87340 |
|
79 |
75 |
$204.64 |
| 86762 |
|
41 |
40 |
$181.36 |
| 86803 |
|
43 |
42 |
$171.25 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
14 |
13 |
$128.42 |
| 86850 |
|
59 |
55 |
$123.69 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
86 |
55 |
$75.56 |
| 86900 |
|
57 |
54 |
$67.99 |
| 86901 |
|
58 |
54 |
$58.84 |
| 87806 |
|
51 |
47 |
$0.00 |
| 87799 |
|
95 |
89 |
$0.00 |
| 87481 |
|
96 |
89 |
$0.00 |
| 81025 |
|
90 |
69 |
$0.00 |
| 87512 |
|
96 |
89 |
$0.00 |
| 87482 |
|
96 |
89 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
77 |
76 |
$0.00 |
| 76830 |
Ultrasound, transvaginal |
56 |
54 |
$0.00 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
216 |
204 |
$0.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
24 |
24 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
12 |
12 |
$0.00 |
| 96127 |
|
12 |
12 |
$0.00 |
| 82950 |
|
13 |
12 |
$0.00 |